Results

Total Results: 2,204 records

Showing results for "drugs".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
    February 16, 2011 - scientific evidence (level A) for using combined oral contraceptives and nonsteroidal anti-inflammatory drugs … Medical therapies • Analgesics o Non-narcotic agents including nonsteroidal anti-inflammatory drugs … Broad searches for grey literature and regulatory information on such commonly used drugs would likely … We consulted the TEP to determine which studies of drugs or devices would be likely to provide relevant … Our research team also thought it important to search for other drugs (e.g., aromatase inhibitors) that
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
    January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … and discrete populations, used different drugs, different dosages, and different cointerventions. … differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin drugsDrugs 2007;67(14):1969-1979. 20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs. Final report. 2006.
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
    November 01, 2016 - Pain Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Possible Side Effects NSAIDs (nonsteroidal anti-inflammatory drugs) – Celecoxib (Celebrex®), diclofenac
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - the Agency for Healthcare Research and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals … , Medicure, Medtronic Vascular, Bristol-Myers Squibb, and Novartis Pharmaceuticals. … Institute, the Agency for Healthcare Research and Quality, Proctor & Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals
  5. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p]. … Get drugs straight to the eye. [internet].
  6. effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-2007/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  7. effectivehealthcare-admin.ahrq.gov/health-topics/eye-diseases
    April 18, 2013 - Research Protocol Archived March 9, 2010 The Effectiveness of Disease-Modifying Antirheumatic Drugs
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
    July 01, 2010 - Exenatide, manufactured as Byetta by Amylin Pharmaceuticals, Inc. … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … In Table 3, we provide details about the other drugs for DM used by these patients. … Experts weigh in on promotion, prescription of off-label drugs. JAMA 2007;297:683-684. 15.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Given the extensive detail on harms for these drugs, we were unable to summarize in a row and have … rather than redoing the entire meta-analysis, we chose to do focused meta- analyses just on those drugs … discussion: “In addition, larger, higher-quality studies have almost all been conducted with new drugs … with pharmaceutical company funding, and these were the only drugs with moderate strength of evidence … treatments improved quality of life, studies were short-term with unclear risk of bias, all oral drugs
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Given the extensive detail on harms for these drugs, we were unable to summarize in a row and have … rather than redoing the entire meta-analysis, we chose to do focused meta- analyses just on those drugs … discussion: “In addition, larger, higher-quality studies have almost all been conducted with new drugs … with pharmaceutical company funding, and these were the only drugs with moderate strength of evidence … treatments improved quality of life, studies were short-term with unclear risk of bias, all oral drugs
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names … provided only for drugs under patent.) … incapaciation and definite hazard to patient's health; adverse events defined according to Compendium of Pharmaceuticals … having a therapeutic effecton the knee joint) no yes Dolorgiet Pharmaceuticals (Germany … Pharmacokinetics, Indications and Dosing of Included Drugs Appendix B.
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
    December 17, 2013 - Thus, major questions of interest are whether or not disease-modifying MS drugs alter the natural history … evidence for patient values, beliefs, and preferences regarding discontinuation of disease- modifying drugs … KQ2: What are individual values, beliefs, and preferences regarding discontinuing disease-modifying drugs … Since these drugs are intended for long-term use, possibly for decades, we are looking for studies that … FDA-approved disease modifying drugs were only available after 1993.
  13. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the five topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p]. … Med Lett Drugs Ther. 2013 Dec 9;55(1431):97-8. PMID: 24322663. 74. … Drugs. 2013 Feb;73(2):187-93. PMID: 23335133.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - significantly for patients with HAP.3-6 Optimal treatment involves choosing the right drug or combination of drugs … For drugs with a narrow therapeutic index, such as vancomycin and the aminoglycosides, the risk of toxicities … also reduce nephrotoxicity in patients who are receiving aggressive dosing, concurrent nephrotoxic drugs … discussion, a new KQ was added to examine the effect of using prolonged or continuous infusions of drugs … creatinine clearance, time above MIC, and ratio of AUC to MIC (see Table 1 below for drug classes and drugs
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - decade ago the FDA established a 12-week duration of observation as a requirement for approval of drugs … behavior in persons with a legitimate (if not always appropriate) need to use the opioid class of drugs … opioid drug abuse and misuse, while simultaneously enabling appropriate access to pain-relieving drugs … Without considering how opioids should be used in the context of other drugs, devices or techniques, … in its class. ii Methadone’s unique properties distinguish it from other opioid drugs.
  16. effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/rapid-research
    February 01, 2024 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  17. effectivehealthcare-admin.ahrq.gov/health-topics/drug-safety
    Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  18. effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders?page=2
    May 02, 2011 - Research Protocol Archived March 9, 2010 The Effectiveness of Disease-Modifying Antirheumatic Drugs
  19. effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/protocol
    September 01, 2023 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  20. S143 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - Key Words: cohort studies, propensity scores, observational research (Med Care 2007;45: S143–S148) Drugs … Statins inhibit endogenous cholesterol synthesis, and ther- apy with these drugs improves lipoprotein … including ambulatory care, approved specialists and outside referrals, laboratory work, and prescription drugs

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: